Colorectal Cancer Coalition

Congressman Boren (D-OK) Announces New Colorectal Cancer Legislation

C3: Colorectal Cancer Coalition is proud to support The Colorectal Cancer Screening and Detection Act of 2007 (HR 3060). Americans age 50-64 are a critical group when considering colorectal cancer. HR 3060 will provide the same protections to non-Medicare beneficiaries that are already provided to Medicare beneficiaries.

Congressman Boren lost his mother to colon cancer nine years ago, and personally understands the need for early detection of the disease.

“Cancer unfortunately has affected millions of lives across the United States,” Boren said. “Coverage is required for many other equally important preventative cancer screenings across the nation. With early detection leading to a 90 percent survival rate, a simple and proven procedure could save the lives of so many (of our) loved ones,” Boren said.

“Colorectal cancer patients have been neglected for too long,” said Carlea Bauman, Executive Director of C3: Colorectal Cancer Coalition. “By providing access to screenings for non-Medicare beneficiaries we will see progress against this terrible disease.”

Studies have shown the monthly cost per patient for full colorectal screening coverage is approximately $2.65, while the savings to the employer for medical and non-medical costs is almost $3.00. Once the patient has been diagnosed with the disease, the same monthly cost climbs to almost $5,000 per patient. Additionally, studies have also shown that doctors do not refer their patients for tests if those tests are not covered by insurance.

“Americans deserve these life saving medical benefits and should be able to count on these protections,” Boren said.

Currently, 22 states, including Texas and the District of Columbia, require coverage. Oklahoma does not currently require coverage of these cancer screenings.

Congressman Ralph Hall (R-TX) has join congressman Boren in his fight.

This news article was originally posted on July 24th, 2007 and was accurate at the time of publication. Since then, information may have changed or links may now be outdated. Please call our Answer Line 1-877-427-2111 for the latest information, or talk to your doctor before making any medical decisions.

Posted by Joe Arite on July 24th, 2007

Leave a Comment Comments RSS

Your comments are welcome. However, specific medical advice will not be provided, and we urge you to consult with a qualified physician for diagnosis and for answers to your personal questions. C3 is not responsible for the medical accuracy of any comments left by persons other than C3 staff members. C3 staff members monitor comments and may respond publicly where appropriate.

Please note that we automatically publish the name that you enter next to your post. Also note that our pages are automatically indexed by Google and other search engines, and your name may therefore appear in search results on those sites. So if you wish to remain anonymous please use a different name or enter 'Anon' as the name.

We regret that we are unable to privately answer questions left as comments. So please do not include your phone number, email or mailing address in the body of your comment. For the best personal and direct response to your colorectal cancer treatment questions, please call our Answer Line at 1-877-4CRC-111 (1-877-427-2111).

Name Email (hidden) URL Comments (Basic HTML is allowed - a href, strong, em, blockquote)